KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Amortization - Intangibles (2021 - 2025)

Pacific Biosciences Of California has reported Amortization - Intangibles over the past 5 years, most recently at $833000.0 for Q4 2025.

  • Quarterly results put Amortization - Intangibles at $833000.0 for Q4 2025, up 120.91% from a year ago — trailing twelve months through Dec 2025 was $6.2 million (down 30.75% YoY), and the annual figure for FY2025 was $364.5 million, up 3780.99%.
  • Amortization - Intangibles for Q4 2025 was $833000.0 at Pacific Biosciences Of California, up from $183000.0 in the prior quarter.
  • Over the last five years, Amortization - Intangibles for PACB hit a ceiling of $5.5 million in Q1 2024 and a floor of -$4.0 million in Q4 2024.
  • Median Amortization - Intangibles over the past 5 years was $741000.0 (2023), compared with a mean of $1.5 million.
  • Peak annual rise in Amortization - Intangibles hit 2908.74% in 2024, while the deepest fall reached 173.56% in 2024.
  • Pacific Biosciences Of California's Amortization - Intangibles stood at -$123000.0 in 2021, then skyrocketed by 248.78% to $183000.0 in 2022, then surged by 2859.56% to $5.4 million in 2023, then crashed by 173.56% to -$4.0 million in 2024, then skyrocketed by 120.91% to $833000.0 in 2025.
  • The last three reported values for Amortization - Intangibles were $833000.0 (Q4 2025), $183000.0 (Q3 2025), and $833000.0 (Q2 2025) per Business Quant data.